3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
7
Esophageal Squamous Cell Carcinoma
3
Esophageal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Advanced Gastric Adenocarcinoma
2
Uterine Cervical Neoplasms
1
Turcot syndrome
1
Stomach Neoplasms
1
Recurrence
1
Pancreatic Neoplasms
1
Liver Neoplasms
1
Liver Diseases
1
Leukemia, Myeloid, Acute
1
Immune Checkpoint Inhibition
1
ESCC
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Bites and Stings
1
Advanced Hepatocellular Carcinoma
1
Interventions
Colonoscopy
19
Early Intervention, Educational
15
Counseling
13
Exercise
11
Methods
10
Oxaliplatin
8
Laparoscopy
8
Preoperative Exercise
7
Blood Specimen Collection
7
Therapeutics
6
Surveys and Questionnaires
5
Standard of Care
5
Saline Solution
5
Psychiatric Rehabilitation
5
Propofol
5
Patient Navigation
5
Magnetic Resonance Imaging
5
Leucovorin
5
Fluorouracil
5
Chemotherapy, Adjuvant
5
Occult Blood
4
Magnetic Resonance Spectroscopy
4
Folfox protocol
4
Diet
4
Cholecalciferol
4
Yoga
3
Sevoflurane
3
Resistance Training
3
Radiotherapy
3
Radiosurgery
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Colonic Neoplasms
×
camrelizumab
×
Clear all
NCT06215677
2025-09-05
NITDC
Peking Union Medical College Hospital
Phase NA
Recruiting
18 enrolled